Then, we verified that Rh2 could suppress the invasion and metastasis ability of NSCLC cells through regulating the EMT process, in line with the role of Rh2 in endometrial cancer [16], cervical cancer [17], and colorectal carcinoma cells [18]. The gene discussed is RHAG; the disease is colorectal carcinoma.